{"id":"https://openalex.org/W59500062","doi":"https://doi.org/10.1080/00034983.1992.11812712","title":"Mefloquine-sulphadoxine-pyrimethamine (Fansimef\u00ae, Roche) in the prophylaxis ofPlasmodium falciparummalaria: a double-blind, comparative, placebo-controlled study","display_name":"Mefloquine-sulphadoxine-pyrimethamine (Fansimef\u00ae, Roche) in the prophylaxis ofPlasmodium falciparummalaria: a double-blind, comparative, placebo-controlled study","publication_year":1992,"publication_date":"1992-01-01","ids":{"openalex":"https://openalex.org/W59500062","doi":"https://doi.org/10.1080/00034983.1992.11812712","mag":"59500062","pmid":"https://pubmed.ncbi.nlm.nih.gov/1304698"},"language":"en","primary_location":{"id":"doi:10.1080/00034983.1992.11812712","doi":"https://doi.org/10.1080/00034983.1992.11812712","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00034983.1992.11812712","pdf_url":null,"source":{"id":"https://openalex.org/S135866459","display_name":"Annals of Tropical Medicine and Parasitology","issn_l":"0003-4983","issn":["0003-4983","1364-8594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320442","host_organization_name":"Maney Publishing","host_organization_lineage":["https://openalex.org/P4310320442"],"host_organization_lineage_names":["Maney Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Tropical Medicine & Parasitology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111594876","display_name":"LATEEF A. SALAKO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181631907","display_name":"University of Ibadan","ror":"https://ror.org/03wx2rr30","country_code":"NG","type":"education","lineage":["https://openalex.org/I181631907"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"L. A. Salako","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria","institution_ids":["https://openalex.org/I181631907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001501803","display_name":"Risquat A. Adio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181631907","display_name":"University of Ibadan","ror":"https://ror.org/03wx2rr30","country_code":"NG","type":"education","lineage":["https://openalex.org/I181631907"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"R. A. Adio","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria","institution_ids":["https://openalex.org/I181631907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037837820","display_name":"O Walker","orcid":"https://orcid.org/0000-0003-3544-419X","observed_orcids":["https://orcid.org/0000-0003-3544-419X"]},"institutions":[{"id":"https://openalex.org/I181631907","display_name":"University of Ibadan","ror":"https://ror.org/03wx2rr30","country_code":"NG","type":"education","lineage":["https://openalex.org/I181631907"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"O. Walker","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria","institution_ids":["https://openalex.org/I181631907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108091127","display_name":"Akintunde Sowunmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181631907","display_name":"University of Ibadan","ror":"https://ror.org/03wx2rr30","country_code":"NG","type":"education","lineage":["https://openalex.org/I181631907"]}],"countries":["NG"],"is_corresponding":false,"raw_author_name":"A. Sowunmi","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, University of Ibadan, Nigeria","institution_ids":["https://openalex.org/I181631907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033441919","display_name":"D St\u00fcrchler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"D. St\u00fcrchler","raw_affiliation_strings":["F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109846001","display_name":"M L Mittelholzer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"M.-L. Mittelholzer","raw_affiliation_strings":["F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017041761","display_name":"Rosemaria Reber-Liske","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"R. Reber-Liske","raw_affiliation_strings":["F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070427004","display_name":"Ute Dickschat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"U. Dickschat","raw_affiliation_strings":["F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffman-La Roche Pharma Clinical Research Department, CH-4200Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6929,"has_fulltext":false,"cited_by_count":12,"citation_normalized_percentile":{"value":0.7020025,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"86","issue":"6","first_page":"575","last_page":"581"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12402","display_name":"Travel-related health issues","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12685","display_name":"Phytochemical compounds biological activities","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mefloquine","display_name":"mefloquine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/sulfadoxine-pyrimethamine","display_name":"sulfadoxine-pyrimethamine","score":0.9290000200271606},{"id":"https://openalex.org/keywords/chloroquine","display_name":"chloroquine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/falciparum-malaria","display_name":"falciparum malaria","score":0.8960000276565552},{"id":"https://openalex.org/keywords/malaria-prophylaxis","display_name":"malaria prophylaxis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/antimalarial-drug-efficacy","display_name":"antimalarial drug efficacy","score":0.7630000114440918},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.7910000085830688},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7919999957084656},{"id":"https://openalex.org/keywords/chloroquine-resistance","display_name":"chloroquine resistance","score":0.7559999823570251},{"id":"https://openalex.org/keywords/parasitaemia-suppression","display_name":"parasitaemia suppression","score":0.8479999899864197},{"id":"https://openalex.org/keywords/endemic-malaria","display_name":"endemic malaria","score":0.43299999833106995},{"id":"https://openalex.org/keywords/ibadan-nigeria","display_name":"Ibadan, Nigeria","score":0.7319999933242798}],"concepts":[{"id":"https://openalex.org/C2777199930","wikidata":"https://www.wikidata.org/wiki/Q736270","display_name":"Mefloquine","level":4,"score":0.8365904092788696},{"id":"https://openalex.org/C2778048844","wikidata":"https://www.wikidata.org/wiki/Q12156","display_name":"Malaria","level":2,"score":0.8060370683670044},{"id":"https://openalex.org/C2778371730","wikidata":"https://www.wikidata.org/wiki/Q311383","display_name":"Plasmodium falciparum","level":3,"score":0.7778785824775696},{"id":"https://openalex.org/C2777035104","wikidata":"https://www.wikidata.org/wiki/Q421072","display_name":"Pyrimethamine","level":4,"score":0.7263116836547852},{"id":"https://openalex.org/C3019824283","wikidata":"https://www.wikidata.org/wiki/Q353172","display_name":"Protozoal disease","level":3,"score":0.5801525115966797},{"id":"https://openalex.org/C2778059366","wikidata":"https://www.wikidata.org/wiki/Q707939","display_name":"Artesunate","level":4,"score":0.5750525593757629},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.528537929058075},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5268610715866089},{"id":"https://openalex.org/C2778301690","wikidata":"https://www.wikidata.org/wiki/Q411557","display_name":"Sulfadoxine","level":5,"score":0.5137327909469604},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4002925455570221},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3224497437477112}],"mesh":[{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000962","descriptor_name":"Antimalarials","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002738","descriptor_name":"Chloroquine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002738","descriptor_name":"Chloroquine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011739","descriptor_name":"Pyrimethamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011739","descriptor_name":"Pyrimethamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013413","descriptor_name":"Sulfadoxine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013413","descriptor_name":"Sulfadoxine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015767","descriptor_name":"Mefloquine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015767","descriptor_name":"Mefloquine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D015767","descriptor_name":"Mefloquine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016778","descriptor_name":"Malaria, Falciparum","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/00034983.1992.11812712","doi":"https://doi.org/10.1080/00034983.1992.11812712","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00034983.1992.11812712","pdf_url":null,"source":{"id":"https://openalex.org/S135866459","display_name":"Annals of Tropical Medicine and Parasitology","issn_l":"0003-4983","issn":["0003-4983","1364-8594"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":"https://openalex.org/P4310320442","host_organization_name":"Maney Publishing","host_organization_lineage":["https://openalex.org/P4310320442"],"host_organization_lineage_names":["Maney Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Tropical Medicine & Parasitology","raw_type":"journal-article"},{"id":"pmid:1304698","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1304698","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of tropical medicine and parasitology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W17920466","https://openalex.org/W1968963419","https://openalex.org/W1976287532","https://openalex.org/W2028134250","https://openalex.org/W2073023079","https://openalex.org/W2086340373","https://openalex.org/W2120148445","https://openalex.org/W2314731117","https://openalex.org/W2409663295","https://openalex.org/W2410103394","https://openalex.org/W2463443112","https://openalex.org/W4254059959"],"related_works":["https://openalex.org/W28523704","https://openalex.org/W2050698401","https://openalex.org/W2059360219","https://openalex.org/W74783696","https://openalex.org/W228809131","https://openalex.org/W2286674676","https://openalex.org/W2410103394","https://openalex.org/W1625482458","https://openalex.org/W2397889750","https://openalex.org/W2401464197"],"abstract_inverted_index":{"From":[0],"July":[1],"1987":[2],"to":[3,29],"June":[4],"1988":[5],"a":[6,16],"randomized,":[7],"double-blind,":[8],"comparative":[9],"placebo-controlled":[10],"field":[11],"trial":[12,167],"was":[13,28,103,160],"conducted":[14],"in":[15,89,95,126,131,136,141,147,157,165,183],"group":[17,144],"of":[18,25,36,80,152,174,180],"villages":[19],"near":[20],"Ibadan,":[21],"Nigeria.":[22],"The":[23],"aim":[24],"the":[26,31,86,90,96,127,132,137,142,148,172,178],"study":[27],"assess":[30],"suppressive":[32],"tolerability":[33],"and":[34,48,54,58,93,145,168],"efficacy":[35],"four":[37,108],"antimalarials":[38,164],"(Fansimef,":[39],"Lariam,":[40],"Fansidar,":[41],"chloroquine)":[42],"given":[43,51],"for":[44,65,154,162,171,177],"24":[45,66,155],"weeks.":[46,67],"Fansimef":[47,97,128,153],"Lariam":[49],"were":[50,114],"with":[52,100],"loading":[53],"maintenance":[55],"doses,":[56],"Fansidar":[57,138],"chloroquine":[59,143],"as":[60],"one":[61,94],"tablet":[62],"per":[63,123],"week":[64],"Of":[68],"567":[69],"enrolled":[70],"subjects,":[71],"114":[72,124],"(20%)":[73],"had":[74],"parasitaemia":[75,102],"on":[76],"entry.":[77],"Eight":[78],"episodes":[79],"symptomatic":[81],"falciparum":[82],"malaria":[83,182],"occurred":[84],"during":[85],"trial,":[87],"seven":[88],"placebo":[91,149],"group,":[92,129,134,139],"group.":[98,150],"Compared":[99],"placebo,":[101],"effectively":[104],"suppressed":[105],"by":[106],"all":[107],"drug":[109,176],"regimens.":[110],"Adverse":[111],"event":[112],"data":[113],"not":[115],"significantly":[116],"different":[117],"between":[118],"groups:":[119],"six":[120],"adverse":[121],"events":[122],"participants":[125],"six/113":[130],"mefloquine":[133],"five/111":[135],"17/115":[140],"eight/114":[146],"Safety":[151],"weeks":[156],"endemic":[158],"areas":[159],"comparable":[161],"standard":[163],"this":[166,175],"provides":[169],"support":[170],"use":[173],"treatment":[179],"resistant":[181],"indigenous":[184],"African":[185],"populations.":[186]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}